Literature DB >> 6385882

Hemodynamic response to naloxone during live Escherichia coli sepsis in splenectomized dogs.

M Rees, J C Bowen.   

Abstract

This study was designed to investigate the concept that endogenous opioids are involved in the pathogenesis of septic shock. Infusion of live Escherichia coli (1.0-1.6 X 10(10) organisms/kg) in splenectomized dogs induced profound hypotension (p less than 0.001), peripheral vasodilatation (p less than 0.001), and metabolic acidosis (p less than 0.05) with maintenance of cardiac index as compared to control splenectomized dogs. Treatment with naloxone (3 mg/kg bolus and 2 mg/kg/hr infusion for 2.5 hours), a specific opiate antagonist, during septic shock attenuated the hypotension (p less than 0.002) and systemic acidosis (p less than 0.02) without altering cardiac index or total peripheral resistance. These experimental results indicate that naloxone may be of therapeutic value in the management of the early vasodilatory stage of septicemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6385882      PMCID: PMC1250545          DOI: 10.1097/00000658-198411000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  34 in total

1.  Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock.

Authors:  D G Reynolds; N J Gurll; T Vargish; R B Lechner; A I Faden; J W Holaday
Journal:  Circ Shock       Date:  1980

2.  Foot-shock induced stress increases beta-endorphin levels in blood but not brain.

Authors:  J Rossier; E D French; C Rivier; N Ling; R Guillemin; F E Bloom
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

3.  Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock.

Authors:  J W Holaday; A I Faden
Journal:  Nature       Date:  1978-10-05       Impact factor: 49.962

Review 4.  Endogenous peptides and analgesia.

Authors:  L Terenius
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

5.  Naloxone in heroin dependence.

Authors:  M Fink; A Zaks; R Sharoff; A Mora; A Bruner; S Levit; A M Freedman
Journal:  Clin Pharmacol Ther       Date:  1968 Sep-Oct       Impact factor: 6.875

6.  Beta-endorphin and parturition.

Authors:  J E Fletcher; T A Thomas; R G Hill
Journal:  Lancet       Date:  1980-02-09       Impact factor: 79.321

7.  Naloxone in irreversible shock.

Authors:  M Tiengo
Journal:  Lancet       Date:  1980-09-27       Impact factor: 79.321

8.  Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock.

Authors:  J W Holaday; A I Faden
Journal:  Brain Res       Date:  1980-05-05       Impact factor: 3.252

9.  Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway.

Authors:  I Lemaire; R Tseng; S Lemaire
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

10.  Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat.

Authors:  A I Faden; J W Holaday
Journal:  J Pharmacol Exp Ther       Date:  1980-03       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.